Roberto Gulminetti

2.1k total citations
39 papers, 667 citations indexed

About

Roberto Gulminetti is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Roberto Gulminetti has authored 39 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 20 papers in Epidemiology and 19 papers in Virology. Recurrent topics in Roberto Gulminetti's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (19 papers) and Hepatitis B Virus Studies (10 papers). Roberto Gulminetti is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (19 papers) and Hepatitis B Virus Studies (10 papers). Roberto Gulminetti collaborates with scholars based in Italy, United States and United Kingdom. Roberto Gulminetti's co-authors include Fausto Baldanti, Stefania Paolucci, Giorgio Barbarini, Arsenio Spinillo, Stefano Novati, Laura Colonna, L Fiorina, Gaia Piazzi, Ezio Capuzzo and P. Marone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Hepatology.

In The Last Decade

Roberto Gulminetti

38 papers receiving 652 citations

Peers

Roberto Gulminetti
Kailapuri G. Murugavel India
Faïza Ajana France
Renato Maserati Italy
Barbara Rossetti Italy
Margrit Carlson United States
Adrien Sawadogo Burkina Faso
Takahiro Aoki Japan
Koldo Aguirrebengoa Spain
Anne Ebel France
Brendan McCarron United Kingdom
Kailapuri G. Murugavel India
Roberto Gulminetti
Citations per year, relative to Roberto Gulminetti Roberto Gulminetti (= 1×) peers Kailapuri G. Murugavel

Countries citing papers authored by Roberto Gulminetti

Since Specialization
Citations

This map shows the geographic impact of Roberto Gulminetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Gulminetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Gulminetti more than expected).

Fields of papers citing papers by Roberto Gulminetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Gulminetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Gulminetti. The network helps show where Roberto Gulminetti may publish in the future.

Co-authorship network of co-authors of Roberto Gulminetti

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Gulminetti. A scholar is included among the top collaborators of Roberto Gulminetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Gulminetti. Roberto Gulminetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Focà, Emanuele, Roberto Gulminetti, Sergio Ferrara, et al.. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. Antiviral Research. 239. 106157–106157.
2.
Calcagno, Andrea, Jessica Cusato, Paola Cinque, et al.. (2024). Serum and CSF biomarkers in asymptomatic patients during primary HIV infection: a randomized study. Brain. 147(11). 3742–3750. 4 indexed citations
3.
Maggiolo, Franco, Roberto Gulminetti, Layla Pagnucco, et al.. (2022). Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients. BMC Infectious Diseases. 22(1). 782–782. 8 indexed citations
4.
Ait‐Khaled, Mounir, Juan Sierra Madero, Vicente Estrada, et al.. (2021). Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies. SHILAP Revista de lepidopterología. 23(1). 9–14. 6 indexed citations
5.
Lombardi, Andrea, Marta Colaneri, Margherita Sambo, et al.. (2020). Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing?. Digestive and Liver Disease. 53(4). 456–460. 1 indexed citations
6.
Bagella, Paola, Nicola Squillace, Elena Ricci, et al.. (2019). <p>Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project</p>. Infection and Drug Resistance. Volume 12. 1385–1391. 21 indexed citations
7.
Paolucci, Stefania, Federica Novazzi, Antonio Piralla, et al.. (2019). <p>Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations</p>. Infection and Drug Resistance. Volume 12. 1975–1984. 4 indexed citations
8.
9.
Paolucci, Stefania, Stefano Novati, Roberto Gulminetti, et al.. (2017). Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs. Scientific Reports. 7(1). 16017–16017. 24 indexed citations
10.
Paolucci, Stefania, Antonio Piralla, L Fiorina, et al.. (2014). Phylogenetic Analysis of HIV Type 1 CRF02_AG in Multiple Genes in Italian and African Patients Living in Italy. AIDS Research and Human Retroviruses. 30(8). 812–818. 1 indexed citations
11.
Paolucci, Stefania, L Fiorina, Antonio Piralla, et al.. (2012). Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients. Virology Journal. 9(1). 245–245. 64 indexed citations
12.
Roccio, Marianna, Barbara Dal Bello, Bárbara Gardella, et al.. (2012). HPV Infection and Intraepithelial Lesions: Comparison Between HIVPositive and Negative Women. Current HIV Research. 10(7). 614–619. 5 indexed citations
13.
Piralla, Antonio, Stefania Paolucci, Roberto Gulminetti, Giuditta Comolli, & Fausto Baldanti. (2011). HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. Virology Journal. 8(1). 149–149. 15 indexed citations
14.
Regazzi, Mario, P. Villani, Roberto Gulminetti, et al.. (2011). Therapeutic Monitoring and Variability of Atazanavir in HIV-Infected Patients, With and Without HCV Coinfection, Receiving Boosted or Unboosted Regimens. Therapeutic Drug Monitoring. 33(3). 303–308. 14 indexed citations
15.
Baldanti, Fausto, et al.. (2009). Early emergence of raltegravir resistance mutations in patients receiving HAART salvage regimens. Journal of Medical Virology. 82(1). 116–122. 36 indexed citations
16.
Paolucci, Stefania, Andrea Foli, Roberto Gulminetti, et al.. (2009). HIV-1 Plasma Variants Encoding Truncated Reverse Transcriptase (RT) in a Patient With High RT-Specific CD8+ Memory T-Cell Response. Current HIV Research. 7(3). 302–310. 3 indexed citations
17.
Novati, Stefano, et al.. (2009). Correlations between atazanavir Ctrough and hyperbilirubinemia: a case report. Journal of Medical Case Reports. 3(1). 9307–9307. 6 indexed citations
18.
Baldanti, Fausto, Stefania Paolucci, Roberto Gulminetti, et al.. (2001). Higher levels of HIV DNA in memory and naive CD4+ T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART. Antiviral Research. 50(3). 197–206. 11 indexed citations
19.
Belloni, C, Angela Pistorio, Carmine Tinelli, et al.. (2000). Early immunisation with hepatitis B vaccine: a five-year study. Vaccine. 18(14). 1307–1311. 30 indexed citations
20.
Marseglia, Gian Luigi, Giuseppe d’Annunzio, Roberto Gulminetti, et al.. (2000). Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. Vaccine. 19(7-8). 680–683. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kailapuri G. Murugavel Breakdown of academic impact, for papers by Faïza Ajana Breakdown of academic impact, for papers by Renato Maserati Breakdown of academic impact, for papers by Barbara Rossetti Breakdown of academic impact, for papers by Margrit Carlson Breakdown of academic impact, for papers by Adrien Sawadogo Breakdown of academic impact, for papers by Takahiro Aoki Breakdown of academic impact, for papers by Koldo Aguirrebengoa Breakdown of academic impact, for papers by Anne Ebel Breakdown of academic impact, for papers by Brendan McCarron
Rankless by CCL
2026